Notably, excess production of IL-23 or transgenic overexpression of the IL-23 receptor has been shown to exacerbate allergen-induced eosinophilic inflammation through Th2 (CD4) cell-dependent mechanisms13. The gene discussed is IL23A; the disease is inflammation.